We are committed to:

  EXPLORING development options in R&D stages:

  • from proof of concepts to Phase II / Phase III
  • to new uses of known compounds that come from academic or industrial initiatives.

WORKING on selecting projects

  • for enhanced development and / or co-development in conjunction with experts from around the world.

SEARCHING for innovative pharmaceutical
treatments aimed at:

  • meeting unmet health needs, including the fields of rare diseases, neglected diseases and subgroups of patients who do not respond to prevalent conditions.

We are committed to:

  EXPLORING development options in R&D stages:

  • from proof of concepts to Phase II / Phase III
  • to new uses of known compounds that come from academic or industrial initiatives.

WORKING on selecting projects

  • for enhanced development and / or co-development in conjunction with experts from around
    the world.

SEARCHING for innovative pharmaceutical
treatments aimed at:

  • meeting unmet health needs, including the fields of rare diseases, neglected diseases and subgroups of patients who do not respond to prevalent conditions.

Building a novel therapeutic path (Preclinic)

  • Considers that repurposed drugs accelerates translation “from the bench to the bedside”.
  • For many severe or currently intractable conditions shortened developments are essential.
  • Qualix DoT helps solving difficulties and adding value to its development.

Testing a new concept (phase II)

  • Reusing approved products reduces risks in patients, lowers regulatory requirements by decreasing development costs and increases attractiveness in the project.
  • Collaborative work is the most advantageous way to carry out ideas. We can help for the cooperation.

Confirming clinical evidence (phase III)

  • The availability of a new indication must be accompanied by affordability for patients and stability for the Health System.
  • The maximum benefit is obtained when the interest of all parties are balanced. Qualix DoT works with well-adjusted proposals.